-
21
-
22
Serum lipids mediate the association of per- and polyfluoroalkyl substances exposure and age-related macular degeneration.
Published 2025-01-01“…<h4>Background</h4>This study aims to investigate the connection between serum lipids, per- and polyfluoroalkyl substances (PFAS), and age-related macular degeneration (AMD) risk and assess whether serum lipids mediate the association between PFAS and AMD.…”
Get full text
Article -
23
Does Cataract Surgery Improve the Progression of Age-Related Macular Degeneration? A Meta-Analysis
Published 2020-01-01“…Cataract and age-related macular degeneration (AMD) are the common causes of blindness in the elderly. …”
Get full text
Article -
24
The amplitude of low frequency fluctuation and spontaneous brain activity alterations in age-related macular degeneration
Published 2025-01-01Subjects: Get full text
Article -
25
En Face OCT Imaging for the Diagnosis of Outer Retinal Tubulations in Age-Related Macular Degeneration
Published 2012-01-01“…Outer retinal tubulations (ORTs) in age-related macular degeneration (AMD) are a recent finding evidenced by spectral-domain OCT. …”
Get full text
Article -
26
Automatic Screening and Grading of Age-Related Macular Degeneration from Texture Analysis of Fundus Images
Published 2016-01-01“…Age-related macular degeneration (AMD) is a disease which causes visual deficiency and irreversible blindness to the elderly. …”
Get full text
Article -
27
-
28
Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration
Published 2025-01-01Subjects: Get full text
Article -
29
Modeling pegcetacoplan treatment effect for atrophic age-related macular degeneration with AI-based progression prediction
Published 2025-02-01Subjects: “…Age-related macular degeneration…”
Get full text
Article -
30
Correlation between ellipsoid zone thickness and the presence of subretinal drusenoid deposits in age-related macular degeneration
Published 2024-08-01“…Purpose Subretinal drusenoid deposits (SDDs) in age-related macular degeneration (AMD) are associated with systemic vascular diseases that compromise ocular perfusion. …”
Get full text
Article -
31
The Relationship between Statin and Risk of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Published 2022-01-01“…Introduction and Aim. Age-related macular degeneration (AMD) is one of the leading causes of blindness and visual defect, particularly in elderly people across the world. …”
Get full text
Article -
32
Preservation of the Photoreceptor Inner/Outer Segment Junction in Dry Age-Related Macular Degeneration Treated by Rheohemapheresis
Published 2015-01-01“…To evaluate the long-term effect of rheohemapheresis (RHF) treatment of age-related macular degeneration (AMD) on photoreceptor IS/OS junction status. …”
Get full text
Article -
33
Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review
Published 2025-03-01Subjects: “…Age-related macular degeneration…”
Get full text
Article -
34
Rehabilitation Methods for Patients with Geographic Atrophy due to Age-Related Macular Degeneration and Effects of Rehabilitation on Quality of Life
Published 2023-01-01“…The purpose of the study is to evaluate the low vision rehabilitation methods and to investigate the effect of visual rehabilitation on quality of life in patients with low vision due to geographic atrophy from age-related macular degeneration (ARMD). Methods. The better-seeing eye of 78 patients with geographic atrophy due to ARMD were included in the study. …”
Get full text
Article -
35
-
36
A cross-tissue transcriptome-wide association study identified susceptibility genes for age-related macular degeneration
Published 2025-02-01Subjects: Get full text
Article -
37
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
Published 2015-01-01“…Age-related macular degeneration (AMD) is the leading cause of substantial and irreversible vision loss amongst elderly populations in industrialized countries. …”
Get full text
Article -
38
Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
Published 2024-05-01“…Objective To evaluate the efficacy and safety of faricimab compared with other anti-vascular endothelial growth factor (anti-VEGF) agents in treating neovascular age-related macular degeneration (nAMD) patients.Methods and analysis A systematic review (SR) was conducted up to January 2023. …”
Get full text
Article -
39
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study
Published 2024-12-01“…Aims To assess the feasibility of a study protocol for a randomised controlled trial of zoledronic acid (ZA) as adjuvant therapy for neovascular age-related macular degeneration (nAMD).Methods In this 1-year, randomised, double-blinded, placebo-controlled pilot study, nAMD patients were allocated 1:1 to receive intravenous ZA 5 mg or placebo at baseline and after 6 months in addition to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy following a treat-and-extend regimen. …”
Get full text
Article -
40
A Novel Smartphone-Based Color Test for Detection of Color Vision Defects in Age Related Macular Degeneration
Published 2022-01-01“…To evaluate the efficacy of the smartphone-based K-color test to detect color defects in patients with Age-related Macular Degeneration (AMD). Methods. 88 patients (n = 135 eyes) with AMD and 28 controls (n = 53 eyes) underwent color testing with the Hardy–Rand–Rittler (H-R-R), the K-color test, and the Ishihara test. …”
Get full text
Article